Takeda Inks US$670 Million Divestment Deal for Europe OTC Biz

April 27, 2020
Takeda Pharmaceutical said on April 24 that it has agreed to sell a portfolio of some 110 select OTC and prescription drugs sold in Europe to Denmark’s Orifarm for up to US$670 million - the latest in a series of...read more